GlobalData on MSN
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...
Researchers discovered that children who went back to school during COVID experienced far fewer mental health diagnoses than ...
Supplements, pseudoscience, and inert treatments abound on social media. Here's why some parents come to believe fake fixes ...
Mental health crises are surprisingly common among high performing Gulf business leaders. Many are travelling abroad for ...
The state of Hawaii has slipped from its top 10 ranking in an annual report that evaluates the health of women and children across the U.S.
inews.co.uk on MSN
Depression, anxiety and PTSD have same genetic roots – what it means for treatment
What are usually seen as 14 different mental health or neurodiversity conditions could really be five clusters of closely ...
The Oxford Student explores how female neurodivergence is likelier to be misdiagnosed in childhood causing increased diagnosis in adulthood.
Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 ...
There are many myths about what ADHD is and is not due to misinformation and misunderstanding about the diagnosis. Unfortunately, many of these myths are even perpetuated by the very providers tasked ...
2don MSN
Study links ADHD to a measurable brain activity pattern, with early signs it may be modifiable
A new study suggests that children with ADHD may exhibit a distinctive, measurable pattern of brain activity that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results